Latest Impairment News

NTAW Holdings reported a reduced half-year loss of $9.7 million on a 12.3% revenue decline, driven by operational challenges and brand distribution changes. The company is focusing on cost restructuring and strategic partnerships to restore growth.

Bapcor Limited reported a statutory loss of $104.8 million for the first half of FY26, alongside an underlying profit in line with guidance. The company announced a $200 million equity raising to strengthen its balance sheet and fund a strategic turnaround.

GTN Limited reported a 14.7% revenue decline to $82.5 million and a significant net loss of $40.9 million for the half-year ended December 2025, driven by a $41.5 million impairment charge. The company also announced a $43.9 million return of capital and a strategic exit from aviation operations in Australia and Canada.

Ramsay Health Care’s half-year results reveal a dramatic net profit rebound, driven by prior year impairments and solid growth in Australia and Europe. The company also announced a strategic acquisition and a proposed share distribution.

Cleanaway Waste Management has upgraded its FY26 underlying EBIT guidance following a strong first half driven by solid waste services growth and successful integration of Contract Resources. The company also announced a 19.6% increase in its interim dividend.

Babylon Pump & Power reported a $7.16 million loss for H1 FY26, weighed down by acquisition-related expenses and an impairment charge, while its rental segment soared post-acquisitions.

CTI Logistics has reported a robust half-year performance with revenue climbing 7.6% and profit before tax soaring 64.2%, underpinned by operational efficiencies and strategic investments in Western Australia.

State Street SPDR Core Equity ETFs have reported consistent half-year results for the period ending 31 December 2025, maintaining alignment with their benchmark indices and continuing to provide reliable distributions to unitholders.

Cyclopharm Limited reported a 17% revenue increase to a record $32.3 million in 2025, powered by a 226% surge in US Technegas sales. The company is accelerating its US rollout with plans for up to 300 installations in 2026, while advancing clinical trials beyond pulmonary embolism.

Elevra Lithium Limited reported an 8% revenue increase and a US$74 million profit for the first half of FY26, driven by higher lithium prices and strategic merger synergies. The company advances its North American Lithium expansion while managing temporary production challenges.

VEEM Ltd posted a significant half-year loss of $19.5 million, driven by a 30% revenue decline and a $24.8 million impairment on gyro product development. Despite setbacks, new product launches and US defence market progress offer a hopeful outlook.

Big River Industries has posted a $1.4 million profit for the half-year ending December 2025, reversing a substantial loss from the previous year, while completing a strategic acquisition in Perth.